Evolent Health (EVH) Receivables - Net (2015 - 2026)

Evolent Health has reported Receivables - Net for 12 years, with the latest figure at $450.5 million in Q2 2026.

• On a quarterly basis, Receivables - Net rose 25.2% year-over-year to $450.5 million in Q2 2026; TTM through Jun 2026 was $450.5 million, a 25.2% increase from a year earlier, with the FY2025 full-year figure at $311.0 million, down 26.12% from the prior year.
• Receivables - Net was $450.5 million for Q2 2026 at Evolent Health, up from $315.0 million in the prior quarter.
• The five-year high for Receivables - Net was $472.4 billion in Q4 2023, with the low at $127.7 million in Q2 2022.
• Average Receivables - Net over 5 years is $26.6 billion, with a median of $371.0 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Receivables - Net jumped 175429.54% in 2023, then tumbled 99.91% in 2024.
• Over 5 years, Receivables - Net stood at $269.1 million in 2022, then surged by 175429.54% to $472.4 billion in 2023, then sank by 99.91% to $420.9 million in 2024, then decreased by 26.12% to $311.0 million in 2025, then soared by 44.86% to $450.5 million in 2026.
• The last three Receivables - Net figures came in at $450.5 million (Q2 2026), $315.0 million (Q1 2026), and $311.0 million (Q4 2025), per Business Quant data.